Lorenzo Monserrat

14.5k total citations · 3 hit papers
172 papers, 7.4k citations indexed

About

Lorenzo Monserrat is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Lorenzo Monserrat has authored 172 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Cardiology and Cardiovascular Medicine, 42 papers in Molecular Biology and 22 papers in Genetics. Recurrent topics in Lorenzo Monserrat's work include Cardiomyopathy and Myosin Studies (98 papers), Cardiovascular Effects of Exercise (55 papers) and Cardiovascular Function and Risk Factors (38 papers). Lorenzo Monserrat is often cited by papers focused on Cardiomyopathy and Myosin Studies (98 papers), Cardiovascular Effects of Exercise (55 papers) and Cardiovascular Function and Risk Factors (38 papers). Lorenzo Monserrat collaborates with scholars based in Spain, United Kingdom and Italy. Lorenzo Monserrat's co-authors include Perry Elliott, William J. McKenna, Claudio Rapezzi, Juan R. Gimeno, Eloisa Arbustini, Sabine Pankuweit, Zofia T. Bilińska, Andre Keren, Luigi Tavazzi and Philippe Charron and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Lorenzo Monserrat

163 papers receiving 7.2k citations

Hit Papers

Classification of the cardiomyopathies: a position statem... 2000 2026 2008 2017 2007 2013 2000 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
    2007 1.9k citations Perry Elliott, Eloisa Arbustini et al. profile →
  2. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
    2013 737 citations Constantinos O’Mahony, Menelaos Pavlou et al. profile →
  3. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
    2000 635 citations Perry Elliott, Lorenzo Monserrat et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorenzo Monserrat Spain 36 6.3k 1.7k 845 704 478 172 7.4k
Yasushi Kitaura Japan 31 1.7k 0.3× 1.1k 0.6× 488 0.6× 618 0.9× 229 0.5× 152 3.3k
Jamshid Shirani United States 34 2.9k 0.5× 1.3k 0.8× 1.0k 1.2× 976 1.4× 576 1.2× 153 4.8k
Page A.W. Anderson United States 31 1.9k 0.3× 772 0.4× 863 1.0× 743 1.1× 505 1.1× 81 3.2k
Saskia C.A. de Jager Netherlands 35 778 0.1× 1.5k 0.9× 487 0.6× 667 0.9× 95 0.2× 129 4.0k
Hideshi Okada Japan 27 1.1k 0.2× 943 0.5× 466 0.6× 531 0.8× 87 0.2× 120 2.7k
Abraham Rothman United States 28 841 0.1× 464 0.3× 1.5k 1.8× 840 1.2× 346 0.7× 116 2.9k
Hyung J. Chun United States 32 515 0.1× 1.8k 1.1× 438 0.5× 1.1k 1.5× 91 0.2× 65 4.5k
Jacques Bonnet France 32 1.0k 0.2× 2.0k 1.2× 257 0.3× 605 0.9× 172 0.4× 112 3.9k
Nadia N. Malouf United States 22 756 0.1× 1.3k 0.8× 145 0.2× 331 0.5× 192 0.4× 34 2.8k
Keishiro Kawamura Japan 34 2.0k 0.3× 885 0.5× 291 0.3× 409 0.6× 442 0.9× 141 3.0k

Countries citing papers authored by Lorenzo Monserrat

Since Specialization
Citations

This map shows the geographic impact of Lorenzo Monserrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Monserrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Monserrat more than expected).

Fields of papers citing papers by Lorenzo Monserrat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Monserrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Monserrat. The network helps show where Lorenzo Monserrat may publish in the future.

Co-authorship network of co-authors of Lorenzo Monserrat

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Monserrat. A scholar is included among the top collaborators of Lorenzo Monserrat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Monserrat. Lorenzo Monserrat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marín, M. Luisa, Ricardo Gómez, Francisco Bermúdez-Jiménez, et al.. (2023). A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family. Proceedings of the National Academy of Sciences. 120(49). e2305135120–e2305135120. 9 indexed citations
2.
Green, Nathan, Yang Chen, Constantinos O’Mahony, et al.. (2023). A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making. European Heart Journal - Quality of Care and Clinical Outcomes. 10(4). 285–293. 4 indexed citations
3.
Pricolo, María Rosaria, Elías Herrero‐Galán, Diego García-Giustiniani, et al.. (2021). Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy. Journal of Biological Chemistry. 297(1). 100854–100854. 22 indexed citations
4.
Hu, Dan, Dan Hu, Dong Hu, et al.. (2020). Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease. EBioMedicine. 54. 102723–102723. 17 indexed citations
5.
Ochoa, Juan Pablo, Luís R. Lopes, Ellie Quinn, et al.. (2020). Deletions of specific exons of FHOD3 detected by next‐generation sequencing are associated with hypertrophic cardiomyopathy. Clinical Genetics. 98(1). 86–90. 12 indexed citations
6.
Salazar‐Mendiguchía, Joel, Roberto Barriales‐Villa, Luís R. Lopes, et al.. (2020). The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals. European Journal of Medical Genetics. 63(12). 104079–104079. 12 indexed citations
7.
Bermúdez-Jiménez, Francisco, Víctor Carriel, Andreas Brodehl, et al.. (2017). Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia. Circulation. 137(15). 1595–1610. 71 indexed citations
8.
Blanco–Penedo, Isabel, et al.. (2014). PERFORMANCE OF CROSSBREED FATTENED CALVES IN COMMERCIAL FARMS IN SPAIN. The Journal of Animal and Plant Sciences. 24(3). 722–729. 2 indexed citations
9.
Arad, Michael, Lorenzo Monserrat, Jonathan G. Seidman, et al.. (2014). Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.. PubMed. 16(11). 707–13. 4 indexed citations
10.
Charron, Philippe, Uzma Aslam, Perry Elliott, et al.. (2013). 098: Pre clinical mutation carriers from families with dilated cardiomyopathy and angiotensin conversion enzyme inhibitor (the PRECARDIA study). Archives of Cardiovascular Diseases Supplements. 5(1). 32–32. 1 indexed citations
11.
Borràs, Xavier, Pastora Gallego, & Lorenzo Monserrat. (2009). Novedades en cardiología clínica: patología de la aorta, miocardiopatía hipertrófica y profilaxis de la endocarditis infecciosa. Revista Española de Cardiología. 62. 28–38. 2 indexed citations
12.
Moreno, T., et al.. (2006). Estudio de la calidad de la carne de ternera de razaRubia Gallega a lo largo de la maduración al vacío. Archivos de Zootecnia. 55(209). 3–14. 12 indexed citations
13.
Monserrat, Lorenzo, Manuel Hermida‐Prieto, Xusto Fernández, et al.. (2006). Mutaciones en el gen de la cadena pesada de la betamiosina en pacientes con miocardiopatía hipertrófica. Revista Española de Cardiología. 59(10). 1008–1018. 22 indexed citations
14.
Hermida‐Prieto, Manuel, et al.. (2006). Mutational Screening of Phospholamban Gene in Hypertrophic and Idiopathic Dilated Cardiomyopathy and Functional Study of the PLN –42 C>G Mutation. European Journal of Heart Failure. 9(1). 37–43. 42 indexed citations
15.
Carballo, J., et al.. (2005). Características de la canal y de la carne de machosprocedentes del cruce de Rubia Gallega con Nelore. Archivos de Zootecnia. 54(206). 485–489. 3 indexed citations
16.
Oliete, Bonastre, et al.. (2004). CATEGORIZACIÓN DE LAS CANALES DE TERNERO PRODUCIDAS EN GALICIA. Archivos de Zootecnia. 53(202). 119–128.
17.
Varela, A., et al.. (2003). Calidad de la carne de machos enteros y castradosDe raza rubia gallega sacrificados con 24 meses. Archivos de Zootecnia. 52(199). 347–358. 1 indexed citations
18.
Beiras, Alfonso Castro, et al.. (2003). Miocardiopatía dilatada familiar: situación actual y beneficios clínicos de la investigación básica. Revista Española de Cardiología. 56(1). 7–12. 4 indexed citations
19.
Peteiro, Jesús, Lorenzo Monserrat, Beatriz Bouzas, & Alfonso Castro‐Beiras. (2002). Effect of Left Ventricular Global Systolic Function, Mitral Regurgitation, and Left Ventricular Inflow Pattern on Exercise Echocardiography Results. Echocardiography. 19(2). 115–123. 6 indexed citations
20.
Monserrat, Lorenzo, et al.. (1998). Non-sustained ventricular tachycardia and sudden death in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 31. 26–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Kitaura Breakdown of academic impact, for papers by Jamshid Shirani Breakdown of academic impact, for papers by Page A.W. Anderson Breakdown of academic impact, for papers by Saskia C.A. de Jager Breakdown of academic impact, for papers by Hideshi Okada Breakdown of academic impact, for papers by Abraham Rothman Breakdown of academic impact, for papers by Hyung J. Chun Breakdown of academic impact, for papers by Jacques Bonnet Breakdown of academic impact, for papers by Nadia N. Malouf Breakdown of academic impact, for papers by Keishiro Kawamura
Rankless by CCL
2026